Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways

Biochemical Pharmacology

Volumn 73, Issue 12, 2007, Pages 1982-1994

  Verhaeghe, Catherine ^a   Remouchamps, Caroline ^a   Hennuy, Benoît ^a   Vanderplasschen, Alain ^a   Chariot, Alain ^a   Tabruyn, Sebastien P ^b   Oury, Cecile ^a   Bours, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GROW   (Netherlands)

Author keywords

AP 1; CFTR; Gene expression; Inflammation; NF B; Transcription factors

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH REGULATED PROTEIN ALPHA; GROWTH REGULATED PROTEIN BETA; GROWTH REGULATED PROTEIN GAMMA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR; PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TRANSFORMED; CHEMOKINES, CXC; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENES, REPORTER; HELA CELLS; HOMOZYGOTE; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LUCIFERASES; MODELS, BIOLOGICAL; MUTATION; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRACHEA; TRANSCRIPTION FACTOR AP-1;

EID: 34247557545     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.03.019     Document Type: Article

References (66)

1. Lyczak J.B., Cannon C.L., and Pier G.B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15 (2002) 194-222
2. Chow C.W., Landau L.I., and Taussig L.M. Bronchial mucous glands in the newborn with cystic fibrosis. Eur J Pediatr 139 (1982) 240-243
3. Ornoy A., Arnon J., Katznelson D., Granat M., Caspi B., and Chemke J. Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am J Med Genet 28 (1987) 935-947
4. Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V. Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros; 2007.
5. Bonfield T.L., Konstan M.W., and Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 104 (1999) 72-78
6. Khan T.Z., Wagener J.S., Bost T., Martinez J., Accurso F.J., and Riches D.W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151 (1995) 1075-1082
7. Noah T.L., Black H.R., Cheng P.W., Wood R.E., and Leigh M.W. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175 (1997) 638-647
8. Mall M., Grubb B.R., Harkema J.R., O'Neal W.K., and Boucher R.C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10 (2004) 487-493
9. Knorre A., Wagner M., Schaefer H.E., Colledge W.H., and Pahl H.L. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs. Biol Chem 383 (2002) 271-282
10. Venkatakrishnan A., Stecenko A.A., King G., Blackwell T.R., Brigham K.L., Christman J.W., et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23 (2000) 396-403
11. Tabary O., Escotte S., Couetil J.P., Hubert D., Dusser D., Puchelle E., et al. Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells. Pflugers Arch 443 Suppl 1 (2001) S40-S44
12. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388 (1997) 548-554
13. Armstrong D.S., Hook S.M., Jamsen K.M., Nixon G.M., Carzino R., Carlin J.B., et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40 (2005) 500-510
14. Dakin C.J., Numa A.H., Wang H., Morton J.R., Vertzyas C.C., and Henry R.L. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 165 (2002) 904-910
15. Delacourt C. Inflammation and cystic fibrosis. Arch Pediatr 10 Suppl 2 (2003) 338s-341s
16. Medjane S., Raymond B., Wu Y., and Touqui L. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 289 (2005) L816-L824
17. Lemnaouar M., Chastre E., Paul A., Mergey M., Veissiere D., Cherqui G., et al. Oncogene-mediated propagation of tracheal epithelial cells from two cystic fibrosis fetuses with different mutations, characterization of CFT-1 and CFT-2 cells in culture. Eur J Clin Invest 23 (1993) 151-160
18. Jungas T., Motta I., Duffieux F., Fanen P., Stoven V., and Ojcius D.M. Glutathione levels and BAX activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator. J Biol Chem 277 (2002) 27912-27918
19. Gruenert D.C., Basbaum C.B., Welsh M.J., Li M., Finkbeiner W.E., and Nadel J.A. Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci USA 85 (1988) 5951-5955
20. Kube D., Sontich U., Fletcher D., and Davis P.B. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 280 (2001) L493-L502
21. Bureau F., Bonizzi G., Kirschvink N., Delhalle S., Desmecht D., Merville M.P., et al. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 161 (2000) 1314-1321
22. Clifton D.R., Rydkina E., Freeman R.S., and Sahni S.K. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha. Infect Immun 73 (2005) 155-165
23. Chariot A., Leonardi A., Muller J., Bonif M., Brown K., and Siebenlist U. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem 277 (2002) 37029-37036
24. Mauro C., Vito P., Mellone S., Pacifico F., Chariot A., Formisano S., et al. Role of the adaptor protein CIKS in the activation of the IKK complex. Biochem Biophys Res Commun 309 (2003) 84-90
25. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res 6 (1996) 986-994
26. Giuliani C., Napolitano G., Bucci I., Montani V., and Monaco F. Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications. Clin Ter 152 (2001) 249-253
27. Viatour P., Merville M.P., and Bours VChariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30 (2005) 43-52
28. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
29. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 (2004) 2195-2224
30. Desmet C., Gosset P., Henry E., Garze V., Faisca P., Vos N., et al. Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. Am J Respir Crit Care Med 172 (2005) 671-678
31. Holzberg D., Knight C.G., Dittrich-Breiholz O., Schneider H., Dorrie A., Hoffmann E., et al. Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. J Biol Chem 278 (2003) 40213-40223
32. Karin M., and Hunter T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 5 (1995) 747-757
33. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63 (1990) 827-834
34. Ward C.L., and Kopito R.R. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem 269 (1994) 25710-25718
35. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4 (2003) P3
36. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270 (1995) 16483-16486
37. Tabary O, Boncoeur E, de Martin R, Pepperkok R, Clement A, Schultz C, et al. Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells. Cell Signal; 2005.
38. - channel function. Am J Physiol Lung Cell Mol Physiol 281 (2001) L71-L78
39. Cigana C., Nicolis E., Pasetto M., Assael B.M., and Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 350 (2006) 977-982
40. 2+ in responses of airway epithelia to Pseudomonas aeruginosa, flagellin, ATP, and thapsigargin. Am J Physiol Lung Cell Mol Physiol 292 (2007) L353-L364
41. Chan M.M., Chmura K., and Chan E.D. Increased NaCl-induced interleukin-8 production by human bronchial epithelial cells is enhanced by the DeltaF508/W1282X mutation of the cystic fibrosis transmembrane conductance regulator gene. Cytokine 33 (2006) 309-316
42. Tchilibon S., Zhang J., Yang Q., Eidelman O., Kim H., Caohuy H., et al. Amphiphilic pyridinium salts block TNF alpha/NF kappa B signaling and constitutive hypersecretion of interleukin-8 (IL-8) from cystic fibrosis lung epithelial cells. Biochem Pharmacol 70 (2005) 381-393
43. Delgado M.A., Poschet J.F., and Deretic V. Nonclassical pathway of Pseudomonas aeruginosa DNA-induced interleukin-8 secretion in cystic fibrosis airway epithelial cells. Infect Immun 74 (2006) 2975-2984
44. Chun K.S., Keum Y.S., Han S.S., Song Y.S., Kim S.H., and Surh Y.J. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 24 (2003) 1515-1524
45. Dhawan P., and Richmond A. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem 277 (2002) 7920-7928
46. Kefaloyianni E., Gaitanaki C., and Beis I. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18 (2006) 2238-2251
47. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22 (2003) 1313-1324
48. Fan Z., Bau B., Yang H., and Aigner T. IL-1beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NFkappaB signaling pathways. Cytokine 28 (2004) 17-24
49. Kida Y., Kobayashi M., Suzuki T., Takeshita A., Okamatsu Y., Hanazawa S., et al. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine 29 (2005) 159-168
50. Petrovic N., Knight D.A., Bomalaski J.S., Thompson P.J., and Misso N.L. Concomitant activation of extracellular signal-regulated kinase and induction of COX-2 stimulates maximum prostaglandin E2 synthesis in human airway epithelial cells. Prostaglandins Other Lipid Mediat 81 (2006) 126-135
51. Blau H, Klein K, Shalit I, Halperin D, Fabian I. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK 1/2, JNK and NF-{kappa}B activation in a cystic fibrosis epithelial cell line. Am J Physiol Lung Cell Mol Physiol; 2006.
52. Nanua S., Sajjan U., Keshavjee S., and Hershenson M.B. Absence of typical unfolded protein response in primary cultured cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 343 (2006) 135-143
53. Ribeiro C.M., Paradiso A.M., Schwab U., Perez-Vilar J., Jones L., O'Neal W., et al. Chronic airway infection/inflammation induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem 280 (2005) 17798-17806
54. 2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappaB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem 281 (2006) 31337-31347
55. Hu Q., Deshpande S., Irani K., and Ziegelstein R.C. [Ca(2+)](i) oscillation frequency regulates agonist-stimulated NF-kappaB transcriptional activity. J Biol Chem 274 (1999) 33995-33998
56. Quinlan K.L., Naik S.M., Cannon G., Armstrong C.A., Bunnett N.W., Ansel J.C., et al. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J Immunol 163 (1999) 5656-5665
57. Han B., and Logsdon C.D. CCK stimulates mob-1 expression and NF-kappaB activation via protein kinase C and intracellular Ca(2+). Am J Physiol Cell Physiol 278 (2000) C344-C351
58. Pier G.B., Grout M., and Zaidi T.S. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 94 (1997) 12088-12093
59. Guggino W.B. The cystic fibrosis transmembrane regulator forms macromolecular complexes with PDZ domain scaffold proteins. Proc Am Thorac Soc 1 (2004) 28-32
60. Yoo D., Flagg T.P., Olsen O., Raghuram V., Foskett J.K., and Welling P.A. Assembly and trafficking of a multiprotein ROMK (Kir 1.1) channel complex by PDZ interactions. J Biol Chem 279 (2004) 6863-6873
61. Wang X., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127 (2006) 803-815
62. DiMango E., Ratner A.J., Bryan R., Tabibi S., and Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101 (1998) 2598-2605
63. Gilmore T.D., and Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25 (2006) 6887-6899
64. Olivier S., Robe P., and Bours V. Can NF-kappaB be a target for novel and efficient anti-cancer agents?. Biochem Pharmacol 72 (2006) 1054-1068
65. Lipecka J., Norez C., Bensalem N., Baudouin-Legros M., Planelles G., Becq F., et al. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J Pharmacol Exp Ther 317 (2006) 500-505
66. - channel activity. J Biol Chem 280 (2005) 5221-5226